CA Stock MarketDetailed Quotes

LABS MediPharm Labs Corp

Watchlist

0.065
0.0000.00%

15min DelayMarket Closed Dec 3 16:00 ET

26.72MMarket Cap-2166P/E (TTM)

MediPharm Labs Corp Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

15.20%9.8M

8.00%10.35M

67.23%9.77M

49.49%33.06M

62.59%9.13M

17.12%8.51M

119.69%9.58M

19.81%5.84M

1.87%22.12M

-2.21%5.62M

Operating revenue

12.02%10.6M

4.64%11.14M

62.74%10.67M

47.38%36.82M

19.76%10.16M

30.27%9.46M

144.02%10.64M

34.45%6.56M

15.07%24.98M

47.69%8.48M

Excise taxes

-16.34%799K

-25.73%788K

26.05%900K

31.09%3.76M

--1.03M

--955K

--1.06M

--714K

--2.87M

----

Cost of revenue

9.69%6.68M

-20.58%6.93M

30.50%7.12M

13.22%27.21M

28.31%6.94M

-27.97%6.09M

78.34%8.73M

3.33%5.46M

-34.98%24.03M

-49.56%5.41M

Gross profit

29.09%3.12M

299.77%3.42M

585.01%2.65M

405.90%5.86M

940.76%2.2M

303.11%2.42M

260.71%855K

196.03%387K

87.45%-1.91M

104.24%211K

Operating expense

-13.94%5.83M

-29.38%5.99M

71.40%6.38M

-12.16%23.6M

5.71%4.63M

-1.23%6.77M

-0.62%8.48M

-47.61%3.72M

-3.22%26.87M

-61.22%4.38M

Selling and administrative expenses

-14.10%5.48M

-26.33%5.93M

78.76%6.5M

0.16%24.8M

24.67%6.74M

19.05%6.38M

17.04%8.05M

-48.96%3.63M

7.48%24.76M

27.28%5.4M

-Selling and marketing expense

-16.60%1.4M

-12.66%1.46M

-2.92%1.33M

20.88%3.16M

25.55%-1.55M

1.45%1.68M

7.34%1.67M

-8.31%1.37M

-43.53%2.62M

-247.24%-2.08M

-General and administrative expense

-13.21%4.08M

-29.90%4.48M

128.12%5.17M

-2.29%21.64M

10.70%8.29M

26.89%4.7M

19.86%6.38M

-59.75%2.27M

20.32%22.14M

164.39%7.49M

Research and development costs

106.56%126K

-49.06%27K

30.56%47K

-79.14%209K

-59.03%59K

-75.60%61K

-82.79%53K

-88.00%36K

-26.05%1M

-75.26%144K

Depreciation amortization depletion

----

-45.49%453K

----

-41.23%831K

----

-Depreciation and amortization

----

-45.49%453K

----

-41.23%831K

----

Provision for doubtful accounts

----

-1,534.33%-1.92M

----

-98.03%134K

----

Other operating expenses

-32.74%226K

-91.32%33K

-434.00%-167K

-54.79%66K

67.23%-700K

-73.14%336K

-71.85%380K

115.67%50K

103.02%146K

-21.99%-2.14M

Operating profit

37.82%-2.71M

66.27%-2.57M

-11.76%-3.73M

38.34%-17.75M

41.66%-2.43M

45.87%-4.36M

15.88%-7.63M

55.58%-3.33M

33.07%-28.78M

74.38%-4.17M

Net non-operating interest income (expenses)

-364.00%-66K

-112.66%-10K

-53.47%114K

6.03%475K

-38.54%126K

-78.45%25K

-2.47%79K

432.61%245K

104.36%448K

105.00%205K

Non-operating interest income

-2.87%169K

5.82%200K

-10.40%224K

75.37%840K

5.58%227K

31.82%174K

125.00%189K

420.83%250K

112.89%479K

179.22%215K

Non-operating interest expense

57.72%235K

90.91%210K

2,100.00%110K

1,077.42%365K

910.00%101K

831.25%149K

3,566.67%110K

150.00%5K

-99.70%31K

143.48%10K

Other net income (expenses)

336.72%3.91M

54.32%-756K

466,800.00%4.67M

-18.24%-1.65M

70.45%-1.66M

Gain on sale of security

----

38.38%-456K

----

-126.03%-740K

45.44%-742K

Special income (charges)

--0

----

578.53%4.37M

67.14%-300K

--0

--4.67M

----

78.47%-913K

---913K

-Less:Restructuring and mergern&acquisition

--0

----

---4.67M

--0

---4.67M

----

--0

-Less:Impairment of capital assets

----

--183K

----

--0

----

-Less:Write off

----

--40K

----

--0

----

-Gain on sale of business

----

72.30%-251K

----

---906K

----

-Gain on sale of property,plant,equipment

----

2,585.71%174K

----

---7K

----

Income before tax

35.94%-2.77M

10.34%-2.58M

-16.94%-3.61M

55.45%-13.36M

45.50%-3.06M

45.40%-4.33M

67.94%-2.88M

58.59%-3.09M

45.16%-29.99M

74.19%-5.62M

Income tax

-4,500.00%-276K

-4,450.00%-273K

-3K

-105.31%-6K

-185.71%-6K

Earnings from equity interest net of tax

Net income

35.89%-2.77M

10.34%-2.58M

-16.94%-3.61M

56.37%-13.08M

50.31%-2.79M

45.44%-4.33M

67.94%-2.88M

58.59%-3.09M

45.29%-29.98M

74.23%-5.61M

Net income continuous operations

35.89%-2.77M

10.34%-2.58M

-16.94%-3.61M

56.37%-13.08M

50.31%-2.79M

45.44%-4.33M

67.94%-2.88M

58.59%-3.09M

45.29%-29.98M

74.23%-5.61M

Noncontrolling interests

Net income attributable to the company

35.89%-2.77M

10.34%-2.58M

-16.94%-3.61M

56.37%-13.08M

50.31%-2.79M

45.44%-4.33M

67.94%-2.88M

58.59%-3.09M

45.29%-29.98M

74.23%-5.61M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

35.89%-2.77M

10.34%-2.58M

-16.94%-3.61M

56.37%-13.08M

50.31%-2.79M

45.44%-4.33M

67.94%-2.88M

58.59%-3.09M

45.29%-29.98M

74.23%-5.61M

Diluted earnings per share

0.00%-0.01

63.64%-0.04

50.00%-0.01

66.67%-0.01

50.00%-0.11

75.00%-0.02

Basic earnings per share

0.00%-0.01

63.64%-0.04

50.00%-0.01

66.67%-0.01

50.00%-0.11

75.00%-0.02

Dividend per share

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	15.20%9.8M	8.00%10.35M	67.23%9.77M	49.49%33.06M	62.59%9.13M	17.12%8.51M	119.69%9.58M	19.81%5.84M	1.87%22.12M	-2.21%5.62M
Operating revenue	12.02%10.6M	4.64%11.14M	62.74%10.67M	47.38%36.82M	19.76%10.16M	30.27%9.46M	144.02%10.64M	34.45%6.56M	15.07%24.98M	47.69%8.48M
Excise taxes	-16.34%799K	-25.73%788K	26.05%900K	31.09%3.76M	--1.03M	--955K	--1.06M	--714K	--2.87M	----
Cost of revenue	9.69%6.68M	-20.58%6.93M	30.50%7.12M	13.22%27.21M	28.31%6.94M	-27.97%6.09M	78.34%8.73M	3.33%5.46M	-34.98%24.03M	-49.56%5.41M
Gross profit	29.09%3.12M	299.77%3.42M	585.01%2.65M	405.90%5.86M	940.76%2.2M	303.11%2.42M	260.71%855K	196.03%387K	87.45%-1.91M	104.24%211K
Operating expense	-13.94%5.83M	-29.38%5.99M	71.40%6.38M	-12.16%23.6M	5.71%4.63M	-1.23%6.77M	-0.62%8.48M	-47.61%3.72M	-3.22%26.87M	-61.22%4.38M
Selling and administrative expenses	-14.10%5.48M	-26.33%5.93M	78.76%6.5M	0.16%24.8M	24.67%6.74M	19.05%6.38M	17.04%8.05M	-48.96%3.63M	7.48%24.76M	27.28%5.4M
-Selling and marketing expense	-16.60%1.4M	-12.66%1.46M	-2.92%1.33M	20.88%3.16M	25.55%-1.55M	1.45%1.68M	7.34%1.67M	-8.31%1.37M	-43.53%2.62M	-247.24%-2.08M
-General and administrative expense	-13.21%4.08M	-29.90%4.48M	128.12%5.17M	-2.29%21.64M	10.70%8.29M	26.89%4.7M	19.86%6.38M	-59.75%2.27M	20.32%22.14M	164.39%7.49M
Research and development costs	106.56%126K	-49.06%27K	30.56%47K	-79.14%209K	-59.03%59K	-75.60%61K	-82.79%53K	-88.00%36K	-26.05%1M	-75.26%144K
Depreciation amortization depletion	----	----	----	-45.49%453K	----	----	----	----	-41.23%831K	----
-Depreciation and amortization	----	----	----	-45.49%453K	----	----	----	----	-41.23%831K	----
Provision for doubtful accounts	----	----	----	-1,534.33%-1.92M	----	----	----	----	-98.03%134K	----
Other operating expenses	-32.74%226K	-91.32%33K	-434.00%-167K	-54.79%66K	67.23%-700K	-73.14%336K	-71.85%380K	115.67%50K	103.02%146K	-21.99%-2.14M
Operating profit	37.82%-2.71M	66.27%-2.57M	-11.76%-3.73M	38.34%-17.75M	41.66%-2.43M	45.87%-4.36M	15.88%-7.63M	55.58%-3.33M	33.07%-28.78M	74.38%-4.17M
Net non-operating interest income (expenses)	-364.00%-66K	-112.66%-10K	-53.47%114K	6.03%475K	-38.54%126K	-78.45%25K	-2.47%79K	432.61%245K	104.36%448K	105.00%205K
Non-operating interest income	-2.87%169K	5.82%200K	-10.40%224K	75.37%840K	5.58%227K	31.82%174K	125.00%189K	420.83%250K	112.89%479K	179.22%215K
Non-operating interest expense	57.72%235K	90.91%210K	2,100.00%110K	1,077.42%365K	910.00%101K	831.25%149K	3,566.67%110K	150.00%5K	-99.70%31K	143.48%10K
Other net income (expenses)				336.72%3.91M	54.32%-756K		466,800.00%4.67M		-18.24%-1.65M	70.45%-1.66M
Gain on sale of security	----	----	----	38.38%-456K	----	----	----	----	-126.03%-740K	45.44%-742K
Special income (charges)	--0	--0	----	578.53%4.37M	67.14%-300K	--0	--4.67M	----	78.47%-913K	---913K
-Less:Restructuring and mergern&acquisition	--0	--0	----	---4.67M	--0	--0	---4.67M	----	--0	--0
-Less:Impairment of capital assets	----	----	----	--183K	----	----	----	----	--0	----
-Less:Write off	----	----	----	--40K	----	----	----	----	--0	----
-Gain on sale of business	----	----	----	72.30%-251K	----	----	----	----	---906K	----
-Gain on sale of property,plant,equipment	----	----	----	2,585.71%174K	----	----	----	----	---7K	----
Income before tax	35.94%-2.77M	10.34%-2.58M	-16.94%-3.61M	55.45%-13.36M	45.50%-3.06M	45.40%-4.33M	67.94%-2.88M	58.59%-3.09M	45.16%-29.99M	74.19%-5.62M
Income tax	0			-4,500.00%-276K	-4,450.00%-273K	-3K			-105.31%-6K	-185.71%-6K
Earnings from equity interest net of tax
Net income	35.89%-2.77M	10.34%-2.58M	-16.94%-3.61M	56.37%-13.08M	50.31%-2.79M	45.44%-4.33M	67.94%-2.88M	58.59%-3.09M	45.29%-29.98M	74.23%-5.61M
Net income continuous operations	35.89%-2.77M	10.34%-2.58M	-16.94%-3.61M	56.37%-13.08M	50.31%-2.79M	45.44%-4.33M	67.94%-2.88M	58.59%-3.09M	45.29%-29.98M	74.23%-5.61M
Noncontrolling interests
Net income attributable to the company	35.89%-2.77M	10.34%-2.58M	-16.94%-3.61M	56.37%-13.08M	50.31%-2.79M	45.44%-4.33M	67.94%-2.88M	58.59%-3.09M	45.29%-29.98M	74.23%-5.61M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	35.89%-2.77M	10.34%-2.58M	-16.94%-3.61M	56.37%-13.08M	50.31%-2.79M	45.44%-4.33M	67.94%-2.88M	58.59%-3.09M	45.29%-29.98M	74.23%-5.61M
Diluted earnings per share	0.00%-0.01	0.00%-0.01	0.00%-0.01	63.64%-0.04	50.00%-0.01	66.67%-0.01	66.67%-0.01	66.67%-0.01	50.00%-0.11	75.00%-0.02
Basic earnings per share	0.00%-0.01	0.00%-0.01	0.00%-0.01	63.64%-0.04	50.00%-0.01	66.67%-0.01	66.67%-0.01	66.67%-0.01	50.00%-0.11	75.00%-0.02
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Top CA Stock Gainers

Symbol Latest Price % Chg

US Critical Metals Corp

USCM

0.080 +128.57%

Mydecine Innovations Group Inc

MYCO

0.010 +100.00%

Three Valley Copper Corp

TVC.H

0.010 +100.00%

Tuga Innovations Inc